Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
National Institutes of Health (NIH) sent this bulletin at 11/16/2020 07:30 AM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
11/16/2020 07:00 AM EST
An interim review of trial data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults.